Product Information |
|
Registration Number |
DR-XY44246
|
Generic Name |
Triptorelin (As Embonate)
|
Brand Name |
Pamorelin
|
Dosage Strength |
3.75 mg
|
Dosage Form |
Lyophilized Powder For Injection (IM/SC)
|
Classification |
Prescription Drug (RX)
|
Packaging |
USP/EP Type I glass vial with grey bromobutyl rubber stopper and aluminum overseal with purple colored plastic flip-off cover (Box of 1's)
|
Pharmacologic Category |
Antineoplastic/ Gonadotropin- Releasing Hormone Analogue
|
Manufacturer |
Debiopharm Research & Manufacturing S.A.
|
Country of Origin |
Switzerland
|
Trader |
Bio-ONCO, Inc.
|
Importer |
UNILAB, Inc.
|
Distributor |
UNILAB, Inc.
|
Application Type |
Initial (from Monitored Release)
|
Issuance Date |
19 April 2022
|
Expiry Date |
27 February 2025
|